Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
Planegg/Martinsried, May 2, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, presented superior T cell...
Noord Holland Pamela Keck Planegg Martinsried International Neoantigen Summit Prime Standard Improved Multi Functionality
Source: marketscreener.com